Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
New insights spotlight how prostate most cancers is now managed as a continual illness, with rising remedies and real-world knowledge providing renewed hope...
July introduced main breast most cancers updates, and CURE is sharing the most recent, as current developments underscore how shortly the panorama continues...
Lung most cancers care has superior at an unprecedented tempo lately, with new therapies regularly reshaping the remedy panorama, in accordance with Dr....
